e-learning
resources
Paris 2018
Sunday, 16.09.2018
Cystic fibrosis in adults: current research
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treatment of atelectasis and severe mucus plugging in cystic fibrosis.
H. Elidottir (Lund, Sweden)
Source:
International Congress 2018 – Cystic fibrosis in adults: current research
Session:
Cystic fibrosis in adults: current research
Session type:
Thematic Poster
Number:
1331
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Elidottir (Lund, Sweden). Treatment of atelectasis and severe mucus plugging in cystic fibrosis.. 1331
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Fungal plug caused segmental atelectasis in a patient with cystic fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 498s
Year: 2006
Airway inflammation in cystic fibrosis
Source: Eur Respir Monogr 2014; 64: 14-31
Year: 2014
Diagnosing bronchiectasis and cystic fibrosis
Source: International Congress 2018 – ME8 Diagnosing bronchiectasis and cystic fibrosis
Year: 2018
Aetiology of non cystic fibrosis bronchiectasis and its correlation with the site of pulmonary damage
Source: Eur Respir J 2003; 22: Suppl. 45, 504s
Year: 2003
Measurement of airways obstruction among preschoolers with cystic fibrosis
Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health
Year: 2008
Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis
Source: ERJ Open Res, 4 (1) 00111-2017; 10.1183/23120541.00111-2017
Year: 2018
The lung microbiome in chronic suppurative lung disease: cystic fibrosis and non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2019; 83: 158-172
Year: 2019
RhDNase after airway clearance therapy improves peripheral airway patency in children with cystic fibrosis
Source: Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs
Year: 2006
Neomacrolides in cystic fibrosis
Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease
Year: 2012
Markers of fibrosis and tissue destruction in usual interstitial pneumonia associated with pulmonary emphysema
Source: Eur Respir J 2007; 30: Suppl. 51, 489s
Year: 2007
Long-term clearance from small airways in patients with cystic fibrosis
Source: Eur Respir J 2005; 25: 317-323
Year: 2005
Massive hemoptysis in cystic fibrosis adult patients
Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health
Year: 2008
Cystic fibrosis fibrosis bronchiectasis
Source: Virtual Congress 2020 – Paediatric year in review
Year: 2020
Regular exercise improves airway inflammation in cystic fibrosis patients
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Bronchial hyperreactivity in cystic fibrosis
Source: Eur Respir J 2002; 20: Suppl. 38, 503s
Year: 2002
Bronchial hyperreactivity in cystic fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 616s
Year: 2004
Significance of small airway obstruction in patients with idiopathic pulmonary fibrosis.
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019
Respiratory infections in cystic fibrosis
Source: ERS Courses: Paediatric respiratory infections
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept